- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Xcelerate
Market Cap: US$8.2m
Acquires engineering/patents and applies to early-stage medical technology companies.
XCRT
US$0.019
7D
2.7%
1Y
-39.0%
WORK Medical Technology Group
Market Cap: US$8.2m
Manufactures and sells medical consumables in the People’s Republic of China and internationally.
WOK
US$0.52
7D
-5.6%
1Y
n/a
Imunon
Market Cap: US$8.1m
A clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines.
IMNN
US$0.48
7D
-39.5%
1Y
-65.4%
Citius Pharmaceuticals
Market Cap: US$8.1m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.85
7D
13.1%
1Y
-94.8%
Resverlogix
Market Cap: CA$11.4m
A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.
RVX
CA$0.04
7D
-11.1%
1Y
-33.3%
Silexion Therapeutics
Market Cap: US$8.1m
A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
SLXN
US$0.92
7D
-7.0%
1Y
-99.1%
Rafarma Pharmaceuticals
Market Cap: US$8.1m
A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.
RAFA
US$0.12
7D
16.0%
1Y
5.5%
Bio Essence
Market Cap: US$8.1m
Operates as a herbal health, diet, and nutrition company in the United States.
BIOE
US$0.21
7D
0%
1Y
n/a
Cambridge Nutritional Sciences
Market Cap: UK£6.1m
Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East.
CNSL
UK£0.025
7D
0%
1Y
-36.3%
Surgical Innovations Group
Market Cap: UK£6.1m
Engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally.
SUN
UK£0.0065
7D
8.3%
1Y
30.0%
Turnstone Biologics
Market Cap: US$8.0m
Operates as a biotechnology company.
TSBX
US$0.34
7D
-1.4%
1Y
-87.4%
Althea Group Holdings
Market Cap: AU$12.5m
Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.
AGH
AU$0.024
7D
4.3%
1Y
-7.7%
Feedback
Market Cap: UK£6.0m
A medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging.
FDBK
UK£0.14
7D
0%
1Y
-81.3%
BioXcel Therapeutics
Market Cap: US$8.0m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$1.45
7D
-5.2%
1Y
-95.6%
Cizzle Biotechnology Holdings
Market Cap: UK£5.9m
Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.
CIZ
UK£0.015
7D
0%
1Y
-10.4%
StimCell Energetics
Market Cap: US$7.8m
A biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States.
STME
US$0.39
7D
76.0%
1Y
23.0%
Kane Biotech
Market Cap: CA$10.8m
A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.
KNE
CA$0.06
7D
-25.0%
1Y
-60.0%
China Pharma Holdings
Market Cap: US$7.7m
Develops, manufactures, and markets pharmaceutical products for human use in the People’s Republic of China.
CPHI
US$2.22
7D
5.0%
1Y
-32.3%
Memphasys
Market Cap: AU$11.9m
Develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.
MEM
AU$0.006
7D
0%
1Y
-25.0%
Intensity Therapeutics
Market Cap: US$7.6m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.
INTS
US$0.42
7D
-22.1%
1Y
-91.4%
Brainstorm Cell Therapeutics
Market Cap: US$7.6m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$1.32
7D
11.9%
1Y
-83.1%
Revive Therapeutics
Market Cap: CA$10.5m
A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.
RVV
CA$0.025
7D
-16.7%
1Y
0%
Lyra Therapeutics
Market Cap: US$7.5m
A clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis.
LYRA
US$0.11
7D
13.7%
1Y
-70.8%
Medicure
Market Cap: CA$10.4m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.00
7D
20.5%
1Y
-1.0%
Carisma Therapeutics
Market Cap: US$7.5m
A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.
CARM
US$0.17
7D
-12.7%
1Y
-88.2%
Incannex Healthcare
Market Cap: US$7.4m
A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.
IXHL
US$0.26
7D
129.1%
1Y
-89.6%
Tissue Repair
Market Cap: AU$11.5m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.19
7D
-2.6%
1Y
-13.6%
BioVaxys Technology
Market Cap: CA$10.3m
A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
BIOV
CA$0.035
7D
16.7%
1Y
-50.0%
Glow Lifetech
Market Cap: CA$10.2m
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
GLOW
CA$0.06
7D
9.1%
1Y
100.0%
Avant Brands
Market Cap: CA$10.1m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.80
7D
-5.9%
1Y
-64.4%
PharmaCyte Biotech
Market Cap: US$7.1m
A biotechnology company, develops and commercializes cellular therapies for cancer in the United States.
PMCB
US$1.06
7D
-4.5%
1Y
-49.5%
Veltex
Market Cap: US$7.1m
Focuses on the development and acquisition of companies that have modalities in the areas of health, wellness, and recovery.
VLXC
US$0.07
7D
-7.3%
1Y
-53.3%
Guided Therapeutics
Market Cap: US$7.0m
A medical technology company, develops medical devices.
GTHP
US$0.13
7D
25.0%
1Y
38.9%
Aptorum Group
Market Cap: US$7.0m
Through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic products for the treatment of oncology and infectious diseases.
APM
US$0.95
7D
10.6%
1Y
-80.0%
Percheron Therapeutics
Market Cap: AU$10.9m
Engages in the research and development of novel antisense pharmaceuticals in Australia.
PER
AU$0.01
7D
0%
1Y
-86.7%
Atomo Diagnostics
Market Cap: AU$10.9m
Engages in the development and sale of medical devices worldwide.
AT1
AU$0.017
7D
0%
1Y
-45.2%